Simulations Plus (NASDAQ:SLP – Get Free Report) posted its quarterly earnings data on Thursday. The technology company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.07, FiscalAI reports. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. The firm had revenue of $21.89 million during the quarter, compared to the consensus estimate of $20.90 million.
Simulations Plus Stock Performance
Shares of NASDAQ SLP traded up $0.07 during trading hours on Thursday, hitting $18.34. 378,542 shares of the stock were exchanged, compared to its average volume of 387,888. The company’s fifty day simple moving average is $16.40 and its two-hundred day simple moving average is $15.48. The company has a market cap of $370.47 million, a PE ratio of -5.86 and a beta of 1.30. Simulations Plus has a 1-year low of $11.09 and a 1-year high of $21.01.
Insider Buying and Selling
In other Simulations Plus news, Director Walter S. Woltosz sold 4,177 shares of the company’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $18.44, for a total transaction of $77,023.88. Following the completion of the sale, the director directly owned 3,202,131 shares in the company, valued at $59,047,295.64. This represents a 0.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 6,177 shares of company stock worth $108,754 in the last three months. 19.10% of the stock is owned by insiders.
Institutional Investors Weigh In On Simulations Plus
Analyst Ratings Changes
SLP has been the subject of a number of analyst reports. Wall Street Zen downgraded shares of Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. Weiss Ratings upgraded Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, June 5th. Craig Hallum cut Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price objective for the company. in a report on Thursday, June 18th. William Blair downgraded Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. Finally, TD Cowen reduced their target price on Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, April 10th. One analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Simulations Plus currently has a consensus rating of “Hold” and a consensus target price of $19.88.
Read Our Latest Analysis on SLP
About Simulations Plus
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Recommended Stories
- Five stocks we like better than Simulations Plus
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
